Cargando…
Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)
BACKGROUND: Colonoscopy screening is underused by first-degree relatives (FDRs) of patients with non-syndromic colorectal cancer (CRC) with screening completion rates below 50%. Studies conducted in FDR referred for screening suggest that fecal immunochemical testing (FIT) was not inferior to colono...
Autores principales: | González-López, Natalia, Quintero, Enrique, Gimeno-Garcia, Antonio Z., Bujanda, Luis, Banales, Jesús, Cubiella, Joaquin, Salve-Bouzo, María, Herrero-Rivas, Jesus Miguel, Cid-Delgado, Estela, Alvarez-Sanchez, Victoria, Ledo-Rodríguez, Alejandro, de-Castro-Parga, Maria Luisa, Fernández-Poceiro, Romina, Sanromán-Álvarez, Luciano, Santiago-Garcia, Jose, Herreros-de-Tejada, Alberto, Ocaña-Bombardo, Teresa, Balaguer, Francesc, Rodríguez-Soler, María, Jover, Rodrigo, Ponce, Marta, Alvarez-Urturi, Cristina, Bessa, Xavier, Roncales, Maria-Pilar, Sopeña, Federico, Lanas, Angel, Nicolás-Pérez, David, Adrián-de-Ganzo, Zaida, Carrillo-Palau, Marta, González-Dávila, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597530/ https://www.ncbi.nlm.nih.gov/pubmed/37874831 http://dx.doi.org/10.1371/journal.pmed.1004298 |
Ejemplares similares
-
Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study
por: Herrero, Jesús-Miguel, et al.
Publicado: (2018) -
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
por: Cubiella, Joaquín, et al.
Publicado: (2016) -
Effect of pravastatin on the survival of patients with advanced gastric cancer
por: Bujanda, Luis, et al.
Publicado: (2015) -
Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models
por: Hijona, Elizabeth, et al.
Publicado: (2012) -
Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study
por: Quintero, Enrique, et al.
Publicado: (2016)